Lestat R Ali - Dept Canc Immunol & Virol, Dana Farber Canc Inst

Lestat Ali,Patrick Lenehan,Victoire Cardot-Ruffino, Andressa Dias Costa, Matthew H.G. Katz, Todd W. Bauer, Jonathan A. Nowak, Brian M. Wolpin, Thomas A. Abrams,Anuj K. Patel, Thomas E. Clancy, Jiping Wang, Joseph D. Mancias,Matthew J. Reilley,Chee-Chee H. Stucky, Tanios Bekaii‐Saab,Rawad Elias, Nipun B. Merchant, Craig L. Slingluff, Osama E. Rahma, Stephanie K. Dougan

openalex（2024）

Cited0Views0Bibtex

Figure S3 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor

Paul E. Oberstein,Andressa Dias Costa,Emily A. Kawaler,Victoire Cardot-Ruffino, Osama E. Rahma,Nina Beri,Harshabad Singh, Thomas A. Abrams,Leah H. Biller,James M. Cleary,Peter Enzinger,Brandon M. Huffman,Nadine J. McCleary,Kimberly J. Perez,Douglas A. Rubinson,Benjamin L. Schlechter,Rishi Surana,Matthew B. Yurgelun,S. Jennifer Wang,Joshua Remland,Lauren K. Brais,Naima Bollenrucher, Eugena Chang,Lestat R. Ali,Patrick J. Lenehan,Igor Dolgalev,Gregor Werba, Cibelle Lima, C. Elizabeth Keheler, Keri M. Sullivan,Michael Dougan,Cristina Hajdu, Maya Dajee,Marc R. Pelletier,Saloney Nazeer,Matthew Squires,Dafna Bar-Sagi,Brian M. Wolpin,Jonathan A. Nowak,Diane M. Simeone, Stephanie K. Dougan

crossref（2024）

Cited0Views0Bibtex

Blockade of IL-1β and PD-1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor

CANCER IMMUNOLOGY RESEARCHno. 9 (2024): 1221-1235

Cited0Views0WOSBibtex

Table S1 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor

crossref（2024）

Cited0Views0Bibtex

Table S2 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor

crossref（2024）

Cited0Views0Bibtex

Biomarkers of Pembrolizumab Efficacy in Advanced Anal Squamous Cell Carcinoma: Analysis of a Phase II Clinical Trial and a Cohort of Long-Term Responders

Journal for immunotherapy of cancer（2024）

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn